Pharmaceutical Investing Aquinox and Astellas Announce Exclusive Licensing Agreement for Rosiptor in the Asia-Pacific Region Including Japan
Pharmaceutical Investing Moleculin Announces Patients Treated in FDA Approved Phase I/II Annamycin Clinical Trial
Pharmaceutical Investing Moleculin Enters Agreement with Seidman Cancer Center to Conduct Leukemia Clinical Trials
Pharmaceutical Investing Moleculin Announces Grant-Funded Collaboration to Expand Understanding of New Discovery
Pharmaceutical Investing Corbus Pharmaceuticals Reports 2017 Financial Results and Provides Clinical Update
Pharmaceutical Investing Calithera Biosciences Reports Fourth Quarter 2017 Financial Results and Recent Highlights
Moleculin Announces Collaboration with Emory University to Develop Novel Treatment of Pediatric Brain Cancer
RUA GOLD Completes the Second Phase of Surface Exploration and Drill Targeting at the Glamorgan Project, New Zealand
Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Escalation Clinical Trial Based on Positive Recommendation from Data Safety and Monitoring Committee
Finlay Minerals Appoints an Executive Chairman, President & CEO, and Vice President, Corporate Development
